Almotriptan

Migraine medication for adolescents

key word:

Migraine adolescents

Category:

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large 'health industry finance platform company integrating pharmaceutical, inte€lligent medical, bio pharmaceutical R&D, industrial production and sales.

The chemical reactions involved in the existing products include Foucault rea¥ction, nitration reaction, sulfonation reaction, hydrogenation reaction, fluorina←tion reaction, chlorination reaction, bromination reaction, diazotization reaction, format reactio♣n, etc.

Migraine medication for adolescents

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed b↑y Merck. In October 2006, Sitagliptin phosphate Januvia was© approved by FDA as the first DPP4 inhibitor for the treatment of type ⅱ diabetes melli¥tus. The characteristics of this drug are that it can stimulate insulin secreti↑on while reducing hunger without causing weight gain. Hypogly‌cemia and edema will not occur, and it is suitable for diδabetic patients with poor blood glucose control and≤ frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical∞ enterprise that is market-oriented and realizes industβrial development through R&D innovation and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most impφortant products for the treatment of arthritis. It is well tolerated and has a low incidence o₩f side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor ©antagonists. In clinical application, it has good ther≠apeutic effect on atopic asthma and other types of bronchial asthma, and the market ≤prospect is huge. In the major category of asthma drugs, leukot¶riene receptor antagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is marke±t-oriented and realizes industrial development through R&D inn<ovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the sec®ond drug approved by FDA for Alzheimer's disease in the United States. Its treatment reaches th≥e target dose and has low toxic and side effects. It has been widely recognized by our medical co©mmunity, and good tolerance is its biggest advantage. In October 1999, Donepezil≈ was launched in China under the trade name "Aricept", which is Ωthe main chemical drug against Alzheimer's disease. At present, CFDA has approved ₩a number of domestic enterprises to produce donepezil preparations, the main do☆sage forms are tablets, capsules, dispersive tablets, oral disintegratin g tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliquis, Bristol-Myers ≥Squibb/Pfizer), a direct oral factor Xa inhibitor, was approved for use in the 27 EU member• states. The world's first drug approved to prevent venouφs thromboembolism (VTE) in adult patients undergoing elective hip or knee replaceme≠nt. From June 2019 to June 2020, the annual sales of apixaban products overseas reache↔d about $15.4 billion, with a year-on-year growth of nearly 32%, and the ♠API consumption reached about 23,960 kg, with a year-on-yeaαr growth of about 28%. Compared with its main competitor, Rivaroxaban, the dεrug's annual overseas sales are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enter÷prise that is market-oriented and realizes industrial development through ←R&D innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On December✔ 29, 2004, it was approved by FDA for the treatment of refractory or relapsed ∏acute lymphoblastic leukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterp₩rise that is market-oriented and realizes industrial development∞ through R&D innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If yoγu need other services, E-mail: 2880705932@qq.com